139 related articles for article (PubMed ID: 36235258)
1. Novel Unsymmetric 3,5-Bis(benzylidene)-4-piperidones That Display Tumor-Selective Toxicity.
Chhikara A; Roayapalley PK; Sakagami H; Amano S; Satoh K; Uesawa Y; Das U; Das S; Borrego EA; Guerena CD; Hernandez CR; Aguilera RJ; Dimmock JR
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235258
[TBL] [Abstract][Full Text] [Related]
2. Novel hybrid molecules of 3,5-bis(benzylidene)-4-piperidones and dichloroacetic acid which demonstrate potent tumour-selective cytotoxicity.
Hossain M; Das S; Das U; Doroudi A; Zhu J; Dimmock JR
Bioorg Med Chem Lett; 2020 Feb; 30(3):126878. PubMed ID: 31864797
[TBL] [Abstract][Full Text] [Related]
3. The cytotoxic properties and preferential toxicity to tumour cells displayed by some 2,4-bis(benzylidene)-8-methyl-8-azabicyclo[3.2.1] octan-3-ones and 3,5-bis(benzylidene)-1-methyl-4-piperidones.
Pati HN; Das U; Das S; Bandy B; De Clercq E; Balzarini J; Kawase M; Sakagami H; Quail JW; Stables JP; Dimmock JR
Eur J Med Chem; 2009 Jan; 44(1):54-62. PubMed ID: 18468733
[TBL] [Abstract][Full Text] [Related]
4. Dimeric 3,5-Bis(benzylidene)-4-piperidones: Tumor-Selective Cytotoxicity and Structure-Activity Relationships.
Das S; Roayapalley PK; Sakagami H; Umemura N; Gorecki DKJ; Hossain M; Kawase M; Das U; Dimmock JR
Medicines (Basel); 2024 Jan; 11(1):. PubMed ID: 38248717
[No Abstract] [Full Text] [Related]
5. Tumour-specific cytotoxicity and structure-activity relationships of novel 1-[3-(2-methoxyethylthio)propionyl]-3,5-bis(benzylidene)-4-piperidones.
Hossain M; Das U; Umemura N; Sakagami H; Balzarini J; De Clercq E; Kawase M; Dimmock JR
Bioorg Med Chem; 2016 May; 24(10):2206-14. PubMed ID: 27073056
[TBL] [Abstract][Full Text] [Related]
6. Discovery and Investigation of 1-[4-(2-Aminoethoxy)Phenylcarbonyl]- 3,5-Bis-(Benzylidene)-4-Piperidones as Candidate Antineoplastic Agents: Our Last 15 Years Study.
Hossain M; Enci CE; Dimmock JR; Das U
Curr Med Chem; 2021; 28(13):2453-2464. PubMed ID: 32744955
[TBL] [Abstract][Full Text] [Related]
7. A novel class of piperidones exhibit potent, selective and pro-apoptotic anti-leukemia properties.
Nunes LM; Hossain M; Varela-Ramirez A; DAS U; Ayala-Marin YM; Dimmock JR; Aguilera RJ
Oncol Lett; 2016 Jun; 11(6):3842-3848. PubMed ID: 27313705
[TBL] [Abstract][Full Text] [Related]
8. Dimeric 3,5-bis(benzylidene)-4-piperidones: a novel cluster of tumour-selective cytotoxins possessing multidrug-resistant properties.
Das S; Das U; Sakagami H; Umemura N; Iwamoto S; Matsuta T; Kawase M; Molnár J; Serly J; Gorecki DK; Dimmock JR
Eur J Med Chem; 2012 May; 51():193-9. PubMed ID: 22409967
[TBL] [Abstract][Full Text] [Related]
9. 1-[4-(2-Dimethylaminoethoxy)phenylcarbonyl]-3,5-Bis(3,4,5-Trimethoxybenzylidene)- 4-Piperidone Hydrochloride and Related Compounds: Potent Cytotoxins Demonstrate Greater Toxicity to Neoplasms than Non- Malignant Cells.
Roayapalley PK; Dimmock JR; Sakagami H; Okudaira N; Sharma RK; Das U
Med Chem; 2022; 18(9):1001-1012. PubMed ID: 35319387
[TBL] [Abstract][Full Text] [Related]
10. Two novel piperidones induce apoptosis and antiproliferative effects on human prostate and lymphoma cancer cell lines.
Swain RM; Contreras L; Varela-Ramirez A; Hossain M; Das U; Valenzuela CA; Penichet ML; Dimmock JR; Aguilera RJ
Invest New Drugs; 2022 Oct; 40(5):905-921. PubMed ID: 35793039
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic N-[4-(3-aryl-3-oxo-1-propenyl)phenylcarbonyl]-3,5-bis(phenylmethylene)-4-piperidones and related compounds.
Dimmock JR; Jha A; Zello GA; Quail JW; Oloo EO; Nienaber KH; Kowalczyk ES; Allen TM; Santos CL; De Clercq E; Balzarini J; Manavathu EK; Stables JP
Eur J Med Chem; 2002 Dec; 37(12):961-72. PubMed ID: 12660021
[TBL] [Abstract][Full Text] [Related]
12. Dichloroacetyl Amides of 3,5-Bis(benzylidene)-4-piperidones Displaying Greater Toxicity to Neoplasms than to Non-Malignant Cells.
Hossain M; Roayapalley PK; Sakagami H; Satoh K; Bandow K; Das U; Dimmock JR
Medicines (Basel); 2022 Jun; 9(6):. PubMed ID: 35736248
[TBL] [Abstract][Full Text] [Related]
13. 3,5-Bis(3-alkylaminomethyl-4-hydroxybenzylidene)-4-piperidones: A Novel Class of Potent Tumor-Selective Cytotoxins.
Karki SS; Das U; Umemura N; Sakagami H; Iwamoto S; Kawase M; Balzarini J; De Clercq E; Dimmock SG; Dimmock JR
J Med Chem; 2016 Jan; 59(2):763-9. PubMed ID: 26727215
[TBL] [Abstract][Full Text] [Related]
14. 3,5-Bis(benzylidene)-1-[4-2-(morpholin-4-yl)ethoxyphenylcarbonyl]-4-piperidone hydrochloride: a lead tumor-specific cytotoxin which induces apoptosis and autophagy.
Das U; Sakagami H; Chu Q; Wang Q; Kawase M; Selvakumar P; Sharma RK; Dimmock JR
Bioorg Med Chem Lett; 2010 Feb; 20(3):912-7. PubMed ID: 20064715
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis and Tumour-Selective Toxicity of Novel 1-[3-{3,5-Bis(benzylidene)-4-oxo-1-piperidino}-3-oxopropyl]-4-piperidone Oximes and Related Quaternary Ammonium Salts.
Roayapalley PK; Dimmock JR; Contreras L; Balderrama KS; Aguilera RJ; Sakagami H; Amano S; Sharma RK; Das U
Molecules; 2021 Nov; 26(23):. PubMed ID: 34885719
[TBL] [Abstract][Full Text] [Related]
16. CLEFMA-an anti-proliferative curcuminoid from structure-activity relationship studies on 3,5-bis(benzylidene)-4-piperidones.
Lagisetty P; Vilekar P; Sahoo K; Anant S; Awasthi V
Bioorg Med Chem; 2010 Aug; 18(16):6109-20. PubMed ID: 20638855
[TBL] [Abstract][Full Text] [Related]
17. Novel Conjugated Unsaturated Ketones with Submicromolar Potencies Towards some Leukemic and Colon Cancer Cells.
Das S; Gul HI; Das U; Balzarini J; Dimmock SG; Dimmock JR
Med Chem; 2019; 15(4):430-438. PubMed ID: 30324886
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic Tumour-Selective 1,5-Diaryl-3-Oxo-1,4-Pentadienes Mounted on a Piperidine Ring.
Roayapalley PK; Sakagami H; Satoh K; Amano S; Bandow K; Aguilera RJ; Hernandez KGC; Schiaffino Bustamante AY; Dimmock SG; Sharma RK; Das U; Dimmock JR
Medicines (Basel); 2021 Dec; 8(12):. PubMed ID: 34940290
[TBL] [Abstract][Full Text] [Related]
19. Novel 3,5-bis(arylidene)-4-oxo-1-piperidinyl dimers: structure-activity relationships and potent antileukemic and antilymphoma cytotoxicity.
Santiago-Vazquez Y; Das S; Das U; Robles-Escajeda E; Ortega NM; Lema C; Varela-Ramírez A; Aguilera RJ; Balzarini J; De Clercq E; Dimmock SG; Gorecki DK; Dimmock JR
Eur J Med Chem; 2014 Apr; 77():315-22. PubMed ID: 24657568
[TBL] [Abstract][Full Text] [Related]
20. Three novel piperidones exhibit tumor-selective cytotoxicity on leukemia cells via protein degradation and stress-mediated mechanisms.
Contreras L; Medina S; Schiaffino Bustamante AY; Borrego EA; Valenzuela CA; Das U; Karki SS; Dimmock JR; Aguilera RJ
Pharmacol Rep; 2022 Feb; 74(1):159-174. PubMed ID: 34448104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
